All data are based on the daily closing price as of June 6, 2025
t

Towa Pharmaceutical

4553.TSE
21.68 USD
-0.60
-2.69%

Overview

Last close
21.68 usd
Market cap
1.07B usd
52 week high
22.81 usd
52 week low
16.09 usd
Target price
28.17 usd

Valuation

P/E
8.1036
Forward P/E
16.7785
Price/Sales
0.5926
Price/Book Value
0.8963
Enterprise Value
2.34B usd
EV/Revenue
1.3072
EV/EBITDA
7.0615

Key financials

Revenue TTM
1.79B usd
Gross Profit TTM
654.03M usd
EBITDA TTM
299.24M usd
Earnings per Share
2.66 usd
Dividend
0.48 usd
Total assets
3.16B usd
Net debt
1.24B usd

About

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products. It also offers IT service related to healthcare; and disease risk testing services. In addition, the company is involved with research and development of diagnostic drugs; and planning, development and OEM manufacturing of health food, pharmaceuticals, general food and other products. The company was founded in 1951 and is headquartered in Osaka, Japan.
  • Symbol
    4553.TSE
  • Exchange
    TSE
  • Isin
    JP3623150004
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Osaka
  • Web site
    https://www.towayakuhin.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top